Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

78.80p
   
  • Change Today:
      1.00p
  • 52 Week High: 171.20p
  • 52 Week Low: 67.00p
  • Currency: UK Pounds
  • Shares Issued: 961.94m
  • Volume: 833,335
  • Market Cap: £758.01m

Dr Martens' US turnaround could see shares recover, says Edison

By Benjamin Chiou

Date: Friday 22 Sep 2023

LONDON (ShareCast) - (Sharecast News) - Equity research firm Edison reckons that Dr Martens' recent share-price underperformance could reverse if the iconic footwear retailer has a successful turnaround of operational issues in North America.


Following a recent "teach-in" day with the company last week, Edison hailed Dr Martens' ongoing product innovation, as well as its brand awareness and relevance among younger demographics through its collaborations with influencers and marketing campaigns on social media.

"DOCS' consumer base is very diverse as well as loyal, with the brand consistently above peers for sentiment scores among UK consumers, which continues to be a driver for the group's global growth prospects," said Russell Pointon, director of the consumer division at Edison.

The company also presented its sustainability strategy as it looks to target natural materials from regenerative agriculture by 2040 and removing fossil-fuel chemicals by 2035.

The shares are currently trading around the 140-150p level, not far off the record low of 113p reached in the summer after full-year results revealed that its North American performance was holding back group sales growth.

The company admitted at the time that it had made "operational mistakes" in the US, such as the move of a distribution centre and the execution of marketing campaigns and online trading. Management called the strategic review and turnaround of the regional business its "number one operational priority".

"DOCS currently trades on discounts of 48% and 32% for EV/EBITDA and P/E, respectively, in FY24 to global luxury, global footwear and sportswear brands. A weak share price performance since IPO in early 2021 due to a combination of operational issues and wider market effects means its valuation, naturally, looks low relative to its historical trading multiples," Pointon said.

He said that this valuation discount to the wider sector could "narrow" based on the performance in North America.

The stock was up 0.4% at 144.44p on Friday.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 78.80p
Change Today 1.00p
% Change 1.29 %
52 Week High 171.20p
52 Week Low 67.00p
Volume 833,335
Shares Issued 961.94m
Market Cap £758.01m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.61% above the market average59.61% above the market average59.61% above the market average59.61% above the market average59.61% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Price Trend
80.3% below the market average80.3% below the market average80.3% below the market average80.3% below the market average80.3% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Income
65.12% above the market average65.12% above the market average65.12% above the market average65.12% above the market average65.12% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
4.76% below the market average4.76% below the market average4.76% below the market average4.76% below the market average4.76% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 04-Jan-24 08-Jun-23
Paid 02-Feb-24 18-Jul-23
Amount 1.56p 4.28p

Trades for 08-May-2024

Time Volume / Share Price
16:35 396,301 @ 78.80p
16:35 824 @ 78.80p
16:35 1,790 @ 78.80p
16:35 6,870 @ 78.80p
16:35 281 @ 78.80p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson

Top of Page